Although it is best known for treating type 2 diabetes, semaglutide — known by its brandname Ozempic — may also be effective ...

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose ...

Indeed, as strict management of hyperglycemia in the Diabetes Control and Complications Trial Research Group trials produced equivocal results in protection against macrovascular complications 4 ...

While more work certainly needs to be done, these data support a major role for the unifying mechanism in the pathogenesis of diabetic macrovascular, as well as microvascular, complications.

Despite the young age, these subjects possess adverse cardiovascular risk profiles and therefore are at risk of macrovascular complications. This case illustrates this point. J.T is a 39-year-old ...